Mirae Asset Global ETFs Holdings
VIR icon

Mirae Asset Global ETFs Holdings’s Vir Biotechnology VIR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
113,338
+6,361
+6% +$50.7K ﹤0.01% 1521
2025
Q4 		$644K Buy
106,977
+1,012
+1% +$6.03K ﹤0.01% 1764
2025
Q3 		$605K Buy
+105,965
New +$542K ﹤0.01% 1779
2025
Q2 		– Sell
-193,378
Closed -$1.25M – 3245
2025
Q1 		$1.25M Sell
193,378
-3,402
-2% -$30.2K ﹤0.01% 1381
2024
Q4 		$1.44M Buy
196,780
+7,110
+4% +$56.1K ﹤0.01% 1348
2024
Q3 		$1.42M Sell
189,670
-29,490
-13% -$256K ﹤0.01% 1340
2024
Q2 		$1.95M Buy
+219,160
New +$2.1M ﹤0.01% 1091

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return